“The results exceeded our expectations and have led to several enquiries from international pharmaceutical companies. Our objective for 2015 is to move NNZ-2566 through development and towards marketing approval as quickly and efficiently as possible," Richard Treagus 30-12-14 ASX announcement.
Richard Treagus' expectations since he joined NEU were enough to get the share price to 14c and raise $21m before the Rett Phase II results. If the results have exceeded his expectations where should the share price be right now?
It will not be long before this sleepy market takes notice. Especially if "several" international pharmaceutical companies have made contact with NEU over these Rett results. The next few weeks/months should be very exciting for Neuren.
.
Low hanging fruit - but not forever
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$19.70 |
Change
0.520(2.71%) |
Mkt cap ! $2.515B | |||
| Open | High | Low | Value | Volume |
| $19.39 | $19.84 | $19.28 | $5.675M | 288.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 1531 | $19.66 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $19.81 | 557 | 1 |
View Market Depth
| Last trade - 16.10pm 03/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$19.70 |
Change
0.520 ( 2.59 %) |
||||
| Open | High | Low | Volume | ||
| $19.50 | $19.84 | $19.28 | 87628 | ||
| Last updated 15.59pm 03/05/2024 ? | |||||
| NEU (ASX) Chart |